Filters

See more specimen types...
See more states

Other countries

See more countries

Results: 1 to 20 of 123

Tests names and labsConditionsGenes and analytesMethods

NF2

Fulgent Genetics
United States
31
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Neurofibromatosis Type 2 (NF2) Next Genetration Sequencing and Deletion/Duplication Testing

Medical Genomics Laboratory Department of Genetics UAB
United States
11
  • L Linkage analysis
  • C Sequence analysis of the entire coding region

NEUROFIBROMATOSI DE TYPE 2 - NF2 gene

Hereditary Cancer Group - Genetic Diagnostic Unit Germans Trias I Pujol Research Institute
Spain
33
  • D Deletion/duplication analysis
  • L Linkage analysis
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region

Neurofibromatosis 2 (NF2)

MVZ Dortmund Dr. Eberhard and Partner
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Schwannomatosis Panel from Biopsy Specimen (NF2, LZTR1, SMARCB1)

Medical Genomics Laboratory Department of Genetics UAB
United States
23
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Neurofibromatosis Type 2 (NF2) Comprehensive Testing from Biopsy Specimen

Medical Genomics Laboratory Department of Genetics UAB
United States
11
  • L Linkage analysis
  • C Sequence analysis of the entire coding region

Meningioma, NF2-related, somatic

Centogene AG - the Rare Disease Company
Germany
11
  • C Sequence analysis of the entire coding region

Neurofibromatosis 2, NF2 Sequencing

Molecular Diagnostics Laboratory Seoul National University Hospital
South Korea
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Neurofibromatosis Type 2 via NF2 Gene Sequencing with CNV Detection

PreventionGenetics
United States
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

NF2 Gene Sequencing

DDC Clinic Molecular Diagnostics Laboratory DDC Clinic, Center for Special Needs Children
United States
31
  • C Sequence analysis of the entire coding region

NF2. Complete sequencing

Instituto de Medicina Genomica
Spain
11
  • C Sequence analysis of the entire coding region

NF2. MLPA testing

Instituto de Medicina Genomica
Spain
11
  • D Deletion/duplication analysis

NF2 gene sequence and deletion/duplication

Ambry Genetics
United States
31
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Neurofibromatosis and Related Disorders , Panel Massive Sequencing (NGS) NF1,NF2,SPRED1 Genes

Reference Laboratory Genetics
Spain
33
  • C Sequence analysis of the entire coding region

Neurofibromatosis Type 2 , Deletions-Duplications (MLPA) NF2 Gene

Reference Laboratory Genetics
Spain
11
  • D Deletion/duplication analysis

Neurofibromatosis Type 2 , Sequencing NF2 Gene

Reference Laboratory Genetics
Spain
11
  • C Sequence analysis of the entire coding region

Single gene testing NF2

CeGaT GmbH
Germany
31
  • C Sequence analysis of the entire coding region

Neurofibromatosis Type 2 (NF2) Evaluation

Athena Diagnostics Inc
United States
21
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Neurofibromatosis Type 2 (NF2) Duplication/Deletion Test

Athena Diagnostics Inc
United States
21
  • D Deletion/duplication analysis

Neurofibromatosis type 2 (sequence analysis of NF2 gene)

CGC Genetics
Portugal
11
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 123

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Support Center